More importantly, Kaplan–Meier analysis revealed that breast cancer patients with low TRIM31 levels had worse survival outcomes than those with high levels in the cancer dataset from the Kaplan–Meier Plotter (Fig. 1g, h). This evidence concerns the gene TRIM31 and cancer.